Cargando…
Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients
BACKGROUND: Obestatin is a ghrelin-associated peptide, derived from preproghrelin. Although many of its effects are unclear, accumulating evidence supports positive actions on both metabolism and cardiovascular function. To date, level of obestatin and its correlations to the lipid subfractions in n...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838862/ https://www.ncbi.nlm.nih.gov/pubmed/29506551 http://dx.doi.org/10.1186/s12944-018-0691-y |
_version_ | 1783304317898326016 |
---|---|
author | Szentpéteri, Anita Lőrincz, Hajnalka Somodi, Sándor Varga, Viktória Evelin Paragh, György Seres, Ildikó Paragh, György Harangi, Mariann |
author_facet | Szentpéteri, Anita Lőrincz, Hajnalka Somodi, Sándor Varga, Viktória Evelin Paragh, György Seres, Ildikó Paragh, György Harangi, Mariann |
author_sort | Szentpéteri, Anita |
collection | PubMed |
description | BACKGROUND: Obestatin is a ghrelin-associated peptide, derived from preproghrelin. Although many of its effects are unclear, accumulating evidence supports positive actions on both metabolism and cardiovascular function. To date, level of obestatin and its correlations to the lipid subfractions in non-diabetic obese (NDO) patients have not been investigated. METHODS: Fifty NDO patients (BMI: 41.96 ± 8.6 kg/m(2)) and thirty-two normal-weight, age- and gender-matched healthy controls (BMI: 24.16 ± 3.3 kg/m(2)) were enrolled into our study. Obestatin level was measured by ELISA. Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) subfractions, intermediate density lipoprotein (IDL) and very low-density lipoprotein (VLDL) levels and mean LDL size were detected by nongradient polyacrylamide gel electrophoresis (Lipoprint). RESULTS: Serum level of obestatin was significantly lower in NDO patients compared to controls (3.01 ± 0.5 vs. 3.29 ± 0.6 μg/ml, p < 0.05). We found significant negative correlations between the level of obestatin and BMI (r = − 0.33; p < 0.001), level of serum glucose (r = − 0.27, p < 0.05), HbA1c (r = − 0.38; p < 0.001) and insulin (r = − 0.34; p < 0.05). Significant positive correlation was found between obestatin level and the levels of ApoA1 (r = 0.25; p < 0.05), large HDL subfraction ratio and level (r = 0.23; p < 0.05 and r = 0.24; p < 0.05), IDL (r = 0.25 p < 0.05) and mean LDL size (r = 0.25; p < 0.05). Serum VLDL ratio and level negatively correlated with obestatin (r = − 0.32; p < 0.01 and r = − 0.21; p = 0.05). In multiple regression analysis obestatin was predicted only by VLDL level. CONCLUSIONS: Based on our data, measurement of obestatin level in obesity may contribute to understand the interplay between gastrointestinal hormone secretion and metabolic alterations in obesity. |
format | Online Article Text |
id | pubmed-5838862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58388622018-03-09 Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients Szentpéteri, Anita Lőrincz, Hajnalka Somodi, Sándor Varga, Viktória Evelin Paragh, György Seres, Ildikó Paragh, György Harangi, Mariann Lipids Health Dis Research BACKGROUND: Obestatin is a ghrelin-associated peptide, derived from preproghrelin. Although many of its effects are unclear, accumulating evidence supports positive actions on both metabolism and cardiovascular function. To date, level of obestatin and its correlations to the lipid subfractions in non-diabetic obese (NDO) patients have not been investigated. METHODS: Fifty NDO patients (BMI: 41.96 ± 8.6 kg/m(2)) and thirty-two normal-weight, age- and gender-matched healthy controls (BMI: 24.16 ± 3.3 kg/m(2)) were enrolled into our study. Obestatin level was measured by ELISA. Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) subfractions, intermediate density lipoprotein (IDL) and very low-density lipoprotein (VLDL) levels and mean LDL size were detected by nongradient polyacrylamide gel electrophoresis (Lipoprint). RESULTS: Serum level of obestatin was significantly lower in NDO patients compared to controls (3.01 ± 0.5 vs. 3.29 ± 0.6 μg/ml, p < 0.05). We found significant negative correlations between the level of obestatin and BMI (r = − 0.33; p < 0.001), level of serum glucose (r = − 0.27, p < 0.05), HbA1c (r = − 0.38; p < 0.001) and insulin (r = − 0.34; p < 0.05). Significant positive correlation was found between obestatin level and the levels of ApoA1 (r = 0.25; p < 0.05), large HDL subfraction ratio and level (r = 0.23; p < 0.05 and r = 0.24; p < 0.05), IDL (r = 0.25 p < 0.05) and mean LDL size (r = 0.25; p < 0.05). Serum VLDL ratio and level negatively correlated with obestatin (r = − 0.32; p < 0.01 and r = − 0.21; p = 0.05). In multiple regression analysis obestatin was predicted only by VLDL level. CONCLUSIONS: Based on our data, measurement of obestatin level in obesity may contribute to understand the interplay between gastrointestinal hormone secretion and metabolic alterations in obesity. BioMed Central 2018-03-05 /pmc/articles/PMC5838862/ /pubmed/29506551 http://dx.doi.org/10.1186/s12944-018-0691-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Szentpéteri, Anita Lőrincz, Hajnalka Somodi, Sándor Varga, Viktória Evelin Paragh, György Seres, Ildikó Paragh, György Harangi, Mariann Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients |
title | Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients |
title_full | Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients |
title_fullStr | Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients |
title_full_unstemmed | Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients |
title_short | Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients |
title_sort | serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838862/ https://www.ncbi.nlm.nih.gov/pubmed/29506551 http://dx.doi.org/10.1186/s12944-018-0691-y |
work_keys_str_mv | AT szentpeterianita serumobestatinlevelstronglycorrelateswithlipoproteinsubfractionsinnondiabeticobesepatients AT lorinczhajnalka serumobestatinlevelstronglycorrelateswithlipoproteinsubfractionsinnondiabeticobesepatients AT somodisandor serumobestatinlevelstronglycorrelateswithlipoproteinsubfractionsinnondiabeticobesepatients AT vargaviktoriaevelin serumobestatinlevelstronglycorrelateswithlipoproteinsubfractionsinnondiabeticobesepatients AT paraghgyorgy serumobestatinlevelstronglycorrelateswithlipoproteinsubfractionsinnondiabeticobesepatients AT seresildiko serumobestatinlevelstronglycorrelateswithlipoproteinsubfractionsinnondiabeticobesepatients AT paraghgyorgy serumobestatinlevelstronglycorrelateswithlipoproteinsubfractionsinnondiabeticobesepatients AT harangimariann serumobestatinlevelstronglycorrelateswithlipoproteinsubfractionsinnondiabeticobesepatients |